Risk Factors for Major Cardiovascular Events in Adult Sepsis Survivors: A Population-Based Cohort Study.
Journal
Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501
Informations de publication
Date de publication:
01 04 2023
01 04 2023
Historique:
pubmed:
16
2
2023
medline:
22
3
2023
entrez:
15
2
2023
Statut:
ppublish
Résumé
To describe risk factors for major cardiovascular events in adults following hospital discharge after sepsis. Population-based cohort study. Ontario, Canada (2008-2017). Adult patients (age 18 yr or older) who survived a first sepsis hospitalization without preexisting cardiovascular disease. None. The primary composite outcome was myocardial infarction, stroke, or cardiovascular death up to 5 years following hospital discharge. We used cause-specific Cox proportional hazards models that accounted for the competing risk of noncardiovascular death to describe factors associated with major cardiovascular events. We identified 268,259 adult patients without cardiovascular disease (median age, 72 yr), of whom 10.4% experienced a major cardiovascular event during a median follow-up of 3 years. After multivariable adjustment, age (hazard ratio [HR], 1.53 for every 10 yr; 95% CI, 1.51-1.54), male sex (HR, 1.23; 95% CI, 1.20-1.26), diabetes mellitus (HR, 1.24; 95% CI, 1.21-1.27), hypertension (HR, 1.34; 95% CI, 1.30-1.38), prevalent atrial fibrillation (HR, 1.46; 95% CI, 1.40-1.52), and chronic kidney disease (HR, 1.11; 95% CI, 1.06-1.16) were associated with major cardiovascular events during long-term follow-up. Sepsis characteristics such as site of infection (pneumonia vs other: HR, 1.09; 95% CI, 1.05-1.12), septic shock (HR, 1.08; 95% CI, 1.05-1.11), and renal replacement therapy (HR, 1.51; 95% CI, 1.38-1.64) were also associated with subsequent cardiovascular events. In an analysis restricting to patients with troponin values measured during the hospitalization (26,400 patients), an elevated troponin was also associated with subsequent cardiovascular events (HR, 1.23; 95% CI, 1.13-1.33). Classic cardiovascular risk factors, comorbid conditions, and characteristics of the sepsis episode were associated with a higher hazard of major cardiovascular events in adult sepsis survivors. These findings may inform enrichment strategies for future studies.
Identifiants
pubmed: 36790198
doi: 10.1097/CCM.0000000000005793
pii: 00003246-202304000-00004
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
471-483Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Déclaration de conflit d'intérêts
Drs. Angriman’s and Scales’s institutions received funding from the University of Toronto Interdepartmental Division of Critical Care Medicine Trainee Research Award and Sepsis Canada Research Network. Dr. Angriman is partially supported by a Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research and a Research Award from the Interdepartmental Division of Critical Care Medicine at the University of Toronto. Dr. Wunsch is partially supported by a Canada Research Chair (Tier 2) in Critical Care Organization and Outcomes. Dr. Lawler is supported by a Heart and Stroke Foundation of Canada National New Investigator Award. Dr. Ko is supported by the Jack Tu Chair in Outcomes Research, Sunnybrook Hospital. Dr. Rosella is supported by a Canada Research Chair in Population Health Analytics. Dr. Martin has disclosed that he does not have any potential conflicts of interest.
Références
Singer M, Deutschman CS, Seymour CW, et al.: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315:801–810
Law AC, Stevens JP, Walkey AJ: National trends in timing of death among patients with septic shock, 1994-2014. Crit Care Med. 2019; 47:1493–1496
Fleischmann C, Scherag A, Adhikari NKJ, et al.: Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016; 193:259–272
Rudd KE, Johnson SC, Agesa KM, et al.: Global, regional, and national sepsis incidence and mortality, 1990–2017: Analysis for the Global Burden of Disease Study. Lancet. 2020; 395:200–211
Seymour CW, Gesten F, Prescott HC, et al.: Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017; 376:2235–2244
Fleuren LM, Klausch TLT, Zwager CL, et al.: Machine learning for the prediction of sepsis: A systematic review and meta-analysis of diagnostic test accuracy. Intensive Care Med. 2020; 46:383–400
Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med. 2013; 369:840–851
Levy MM, Evans LE, Rhodes A: The surviving sepsis campaign bundle: 2018 update. Crit Care Med. 2018; 46:997–1000
Shankar-Hari M, Saha R, Wilson J, et al.: Rate and risk factors for rehospitalisation in sepsis survivors: Systematic review and meta-analysis. Intensive Care Med. 2020; 46:619–636
Prescott HC, Osterholzer JJ, Langa KM, et al.: Late mortality after sepsis: Propensity matched cohort study. BMJ. 2016; 353:i2375
Dalager-Pedersen M, Søgaard M, Schønheyder HC, et al.: Risk for myocardial infarction and stroke after community-acquired bacteremia: A 20-year population-based cohort study. Circulation. 2014; 129:1387–1396
Prescott HC, Angus DC: Enhancing recovery from sepsis: A review. JAMA. 2018; 319:62–75
Mankowski RT, Yende S, Angus DC: Long-term impact of sepsis on cardiovascular health. Intensive Care Med. 2019; 45:78–81
Yende S, Kellum JA, Talisa VB, et al.: Long-term host immune response trajectories among hospitalized patients with sepsis. JAMA Netw Open. 2019; 2:e198686
Lone NI, Gillies MA, Haddow C, et al.: Five-year mortality and hospital costs associated with surviving intensive care. Am J Respir Crit Care Med. 2016; 194:198–208
Shankar-Hari M, Harrison DA, Ferrando-Vivas P, et al.: Risk Factors at index hospitalization associated with longer-term mortality in adult sepsis survivors. JAMA Netw Open. 2019; 2:e194900
Prescott HC, Langa KM, Liu V, et al.: Increased 1-year healthcare use in survivors of severe sepsis. Am J Respir Crit Care Med. 2014; 190:62–69
Kosyakovsky LB, Angriman F, Katz E, et al.: Association between sepsis survivorship and long-term cardiovascular outcomes in adults: A systematic review and meta-analysis. Intensive Care Med. 2021; 47:931–942
Farrah K, McIntyre L, Doig CJ, et al.: Sepsis-associated mortality, resource use, and healthcare costs: A propensity-matched cohort study*. Crit Care Med. 2021; 49:215–227
Angriman F, Rosella L, Lawler P, et al.: Sepsis hospitalization and risk of subsequent cardiovascular events in adults: A population-based matched cohort study. Intensive Care Med. 2022; 48:448–457
Yende S, Linde-Zwirble W, Mayr F, et al.: Risk of cardiovascular events in survivors of severe sepsis. Am J Respir Crit Care Med. 2014; 189:1065–1074
Corrales-Medina VF, Alvarez KN, Weissfeld LA, et al.: Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015; 313:264–274
Ou S-MM, Chu H, Chao P-WW, et al.: Long-term mortality and major adverse cardiovascular events in sepsis survivors a nationwide population-based study. Am J Respir Crit Care Med. 2016; 194:209–217
Garcia MA, Rucci JM, Thai KK, et al.: Association between troponin I levels during sepsis and postsepsis cardiovascular complications. Am J Respir Crit Care Med. 2021; 204:557–565
Mayr FB, Prescott HC: Identifying survivors of sepsis at risk for adverse cardiovascular outcomes. Am J Respir Crit Care Med. 2021; 204:500–501
Merdji H, Schini-Kerth V, Meziani F, et al.: Long-term cardiovascular complications following sepsis: Is senescence the missing link?. Ann Intensive Care. 2021; 11:166
Walkey AJ, Knox DB, Myers LC, et al.: Prognostic accuracy of presepsis and intrasepsis characteristics for prediction of cardiovascular events after a sepsis hospitalization. Crit Care Explor. 2022; 4:e0674
Shankar-Hari M, Rubenfeld GD: Population enrichment for critical care trials: Phenotypes and differential outcomes. Curr Opin Crit Care. 2019; 25:489–497
Riley RD, Hayden JA, Steyerberg EW, et al.: Prognosis research strategy (PROGRESS) 2: Prognostic factor research. PLoS Med. 2013; 10:e1001380
von Elm E, Altman DG, Egger M, et al.: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet. 2007; 370:1453–1457
Lee KJ, Tilling KM, Cornish RP, et al.: Framework for the treatment and reporting of missing data in observational studies: The treatment and reporting of missing data in observational studies framework. J Clin Epidemiol. 2021; 134:79–88
Chen G, Farris MS, Cowling T, et al.: Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study. Clin Cardiol. 2021; 44:1613–1620
Tu J, Chu A, Donovan LR, et al.: The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): Using big data to measure and improve cardiovascular health and healthcare services. Circ Cardiovasc Qual Outcomes. 2015; 8:2014–2012
Jolley RJ, Quan H, Jette N, et al.: Validation and optimisation of an ICD-10-coded case definition for sepsis using administrative health data. BMJ Open. 2015; 5:e0094871–e0094810
Jolley RJ, Sawka KJ, Yergens DW, et al.: Validity of administrative data in recording sepsis: A systematic review. Crit Care. 2015; 19:139
Austin PC, Daly PA, Tu JA multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J. 2002; 144:290–296
Porter J, Mondor L, Kapral MK, et al.: How reliable are administrative data for capturing stroke patients and their care. Cerebrovasc Dis Extra. 2016; 6:96–106
Austin PC, Lee DS, Fine JP: Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016; 133:601–609
Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94:496509
Madley-Dowd P, Hughes R, Tilling K, et al.: The proportion of missing data should not be used to guide decisions on multiple imputation. J Clin Epidemiol. 2019; 110:63–73
He Y: Missing data analysis using multiple imputation: Getting to the heart of the matter. Circ Cardiovasc Qual Outcomes. 2010; 3:98–105
Sheyin O, Davies O, Duan W, et al.: The prognostic significance of troponin elevation in patients with sepsis: A meta-analysis. Heart Lung. 2015; 44:75–81
Mccaw ZR, Claggett BL, Tian L, et al.: Practical recommendations on quantifying and interpreting treatment effects in the presence of terminal competing risks: A review. JAMA Cardiol. 2021; 7:450–456
Charlson ME, Pompei P, Ales KL, et al.: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987; 40:373–383
Musher DM, Abers MS, Corrales-Medina VF: Acute infection and myocardial infarction. N Engl J Med. 2019; 380:171–176
Jafarzadeh SR, Thomas BS, Warren DK, et al.: Longitudinal study of the effects of bacteremia and sepsis on 5-year risk of cardiovascular events. Clin Infect Dis. 2016; 63:495–500
Myers LC, Knox D, Thai KK, et al.: Predicting post-sepsis cardiovascular events with death as a competing risk. Ann Am Thorac Soc. 2022; 1:14
Yende S, D’Angelo G, Mayr F, et al.: Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths. PLoS One. 2011; 6:e22847
Alnabelsi TS, Gupta VA, Su LC, et al.: Usefulness of findings by multimodality imaging to stratify risk of major adverse cardiac events after sepsis at 1 and 12 months. Am J Cardiol. 2020; 125:1732–1737
Lai CC, Lee MTG, Lee WC, et al.: Susceptible period for cardiovascular complications in patients recovering from sepsis. CMAJ. 2018; 190:E1062–E1069
Westreich D, Greenland S: The table 2 fallacy: Presenting and interpreting confounder and modifier coefficients. Am J Epidemiol. 2013; 177:292–298